AbbVie Inc. (ABBV)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
At close: 04:03PM EST
After hours:
| Previous Close | 145.14 |
| Open | 145.41 |
| Bid | 144.85 x 1000 |
| Ask | 144.86 x 800 |
| Day's Range | 144.48 - 146.35 |
| 52 Week Range | 134.09 - 175.91 |
| Volume | |
| Avg. Volume | 5,489,368 |
| Market Cap | 255.74B |
| Beta (5Y Monthly) | 0.65 |
| PE Ratio (TTM) | 49.64 |
| EPS (TTM) | 2.91 |
| Earnings Date | Jan 31, 2023 - Feb 06, 2023 |
| Forward Dividend & Yield | 5.64 (3.67%) |
| Ex-Dividend Date | Oct 13, 2022 |
| 1y Target Est | 158.66 |
- Zacks
Will AbbVie's (ABBV) New Drugs Continue to Drive Q4 Earnings?
AbbVie's (ABBV) fourth-quarter performance is expected to reflect the impact of strong demand for immunology and neuroscience products.
- Motley Fool
3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income
Would you like a stock portfolio that generates enough passive income to fuel your retirement dreams? Unlike most areas of the economy, healthcare services are a top priority in good economic times and bad. Here's why investors who buy them now could end up with a big passive income stream that continues growing for the rest of their lives.
- Zacks
AbbVie (ABBV) to Report Q4 Earnings: What's in the Cards?
AbbVie's (ABBV) Q4 performance will likely reflect strong drug demand from its immunology and neuroscience franchises. Investors will also enquire about ABBV's plans to counter Humira LOE.
© 2023 Yahoo. All rights reserved.
